Skip to content

Lifecore Biomedical, Inc. LFCR Reportable Segment — Stock-Based Comp

Similar metrics at other companies

Mirum Pharmaceuticals, Inc. logo
MIRMReportable Segment — Stock-Based Comp
$57.13M+269%
Arlo Technologies logo
ARLOReportable Segment — Stock-Based Comp
$18.36M+15.5%
Energy Vault Holdings logo
NRGVReportable Segment — Stock-Based Comp
$7.05M-24.0%
Alto Neuroscience logo
ANROReportable segment — Stock-Based Comp
$2.82M+43.5%
Marcus & Millichap logo
MMIReportable Segment — Stock-Based Comp
$6.62M+7.1%
KRT
KRTReportable Segment — Stock-Based Comp
$242K-30.1%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-37.3%
Enterprise value$333.06M+6.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s reportable segment — stock-based comp?
Lifecore Biomedical, Inc. (LFCR) reported reportable segment — stock-based comp of $1.7M in Q1 2026.
What does reportable segment — stock-based comp mean?
This metric quantifies the non-cash expense recognized for equity-based awards granted to employees and management within the segment. It is an important measure for understanding the total cost of talent and the potential dilution impact on shareholders.